Home / Health / AIIMS Syringe Recall: Patient Safety Measure Confirmed
AIIMS Syringe Recall: Patient Safety Measure Confirmed
5 Aug
Summary
- AIIMS recalled certain disposable syringe batches due to quality complaints.
- Two manufacturers, Noble Pharmacare and Veekay Surgicals, supplied affected batches.
- No adverse patient effects were reported following the recall.
Earlier this year, the All India Institute of Medical Sciences (AIIMS) in Delhi initiated a recall of certain disposable syringe batches. This action was a direct response to quality complaints received from its user departments. The affected syringes were supplied by Noble Pharmacare Ltd. and Veekay Surgicals.
The Union Health Ministry confirmed on Wednesday, August 5, 2026, that the recall was undertaken as a precautionary measure for patient safety. While quality defects prompted the withdrawal, the Ministry stated that no adverse effects on patients have been reported to date.
In response to the issue, show-cause notices have been issued to both manufacturing firms. The entire stock of the recalled batches has since been replaced with fresh supplies. AIIMS maintains stringent procurement protocols, including random sampling and inspection, to ensure the quality of medical devices.
A dedicated Patient Safety and Quality Cell has been established at AIIMS to analyze such incidents and implement corrective measures, aiming to prevent future occurrences.
